8/6/2019 NE Bulletin March 2011 FINAL

http://slidepdf.com/reader/full/ne-bulletin-march-2011-final 1/2

 News and events bulletinevents@enterprise.cam.ac.uk  March 2011

Cambridge inventions and portfolio companies in the news

Study shows new peanut allergy treatment works Enecsys solar PV micro-inverter scoops technology award from expert cleantech forum Phylogica to form drug discovery spin-off with University of Cambridge Popcode brings a new reality to the Science Festival  Cambridge CMOS Sensors receives further University funding Granta Design expands in US & Germany TeraView strengthens Cambridge relationship Breathing Buildings announces major collaboration project English at your fingertips Astex announces milestone in oncology collaboration The positive impact of academic innovations on quality of life 

Cambridge spin-outs recognised at European entrepreneurship awards

Two Cambridge Enterprise portfolio companies were recognised in the thirdannual ACES awards, held in Zurich on 3 February and awarded by theScience|Business Innovation Board.

Sabine Bahn and Chris Lowe, co-founders of Psynova Neurotech receivedthe Life Sciences Award, and Carlos Ludlow and Howard Chase of Enval

Limited were recognised in the Materials/Chemistry category.

The ACES is a pan-European competition among companies spun out fromuniversities to recognise the best academic entrepreneurs from across alltechnology disciplines. The competition is open to entrepreneurs in the

European Union and countries affiliated with European Union’s 7th Framework Programme for research,including Israel and Russia. This year, the ACES drew nominations from Europe to Bashkorostan andculminated in an awards ceremony hosted by the ETH Zurich. Read more 

Follow us on Twitter for updates on the DiscoveryFund, Cambridge Enterprise Seed Funds and our 

portfolio companies.

8/6/2019 NE Bulletin March 2011 FINAL

http://slidepdf.com/reader/full/ne-bulletin-march-2011-final 2/2

 Licensing opportunities

A selection of some of the latestlicensing opportunities availablethrough Cambridge Enterprise:

Macrolide antibiotic as anantiviral agent ● Novelhomeostatic peptides ● Insectresistant surfaces ● Improvedultrasound imaging techniques● Methods to inducedifferentiation of embryonicstem cells ● Cell culture modelfor Huntingdon’s Disease ●Novel bacteriophage resistancesystem ● Predicting auto-immune disease progression ●

Novel marker for cancer diagnosis ● Transgenic mousemodel for immunological studies● Efficient nonlinear opticalchromophores ● Coating of nanoscale arrays ● Apparatusfor ultra-low volume fluidsensing ● Electrolytic productionof carbon nanotubes ●Improved thyristor device ●

Click here for further details on

these and more licensingopportunities.

Research Reagents

Antibodies, cell lines, proteins,DNA constructs, plasmids andother reagents generated byresearchers are the foundationfor much biological research. Aselection of research reagents isavailable here. Alternatively,

please contact us directly withyour specific requirements.

Enterprise Network

The University EnterpriseNetwork (UEN) helps supportthe flow of information tostudents and staff about thewide range of entrepreneurshipand innovation activitiesavailable to help raise

awareness, develop skills andprovide direct advice andsupport.

Business Weekly and CfEL launch Cambridge GraduateEntrepreneur of the Year Award

A new prize to honour entrepreneurship at theUniversity of Cambridge has

been launched to commemoratethe 21st Anniversary East of England Business Awards.

The Centre for EntrepreneurialLearning at Judge BusinessSchool is sponsoring a

Cambridge Graduate Business of the Year Award, which will bepresented for the first time at a gala dinner on March 24 at Queens’College, Cambridge and will then be awarded in perpetuity.

The award is designed to recognise the most innovative enterprise

launched by a Cambridge graduate. To qualify, a business enterprisefounded by a Cambridge graduate should have typically enjoyed aminimum of three years outside of the immediate University compassand gained at least a modicum of commercial success. Read more 

Forthcoming events of interest

8th Biotechnology Investment ForumThursday, 19 May 2011

Babraham Research Campus, Cambridge

This one day event provides showcasing of a wide selection of newtechnologies pioneered by upcoming innovative biotech companiesfrom across the UK which enables investors to listen to a number of high quality company presentations in one day. The companiespresent their objectives and financial requirements, through formalpresentations and informal discussion.

For more information, or to apply for a place, click here. 

Technology Ventures Conference 2011Thursday, 9 June 2011Cambridge Union, Cambridge

TVC2011 will address the importance of Ideas Economy, specificallythe process of implementing this as well as examine the effect in hightech clusters including Cambridge. It will provide delegates theopportunity to understand the concept, its benefits and applicablescenarios through direct engagement, connectivity of ideas, andproblem solving at a networking level. Finally, TVC 2011 will aim toprovide delegates a platform to create new ideas, form new business

relationships and most importantly – catalyse inspiration.

For more information, or to book a place at this event, click here.